Analgesic Solutions will present proprietary tools and research posters at five conferences in 2018. We invite you to meet our team presenting the following research posters.
If you would like to schedule a meeting at any of the conferences or would like to learn more about the information being presenting, please contact Tony May at email@example.com or 781-444-9605 x120.
- American Academy of Pain (Vancouver, Canada):
“Assessment of a Systematic Framework to Determine the Equianalgesic Conversion Ratio Between Opioids: Determining the Conversion Ratio Between Tapentadol and Morphine”
- College of Problems of Drug Dependence (San Diego, CA):
“Nektar: Phase 3, Double-Blind, Placebo Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naïve Subjects with Moderate to Severe Chronic Low Back Pain”
“Assessment of Drug-Abuse Related Events with MADDERS in SUMMIT-07: A Phase-3 Study of NKTR-181 in Patients with Moderate to Severe Chronic Low-Back Pain”
- DIA 2018 Global Annual Meeting (Boston, MA):
“MADDERS: A Systematic Approach to Meeting Regulatory Requirements for Evaluating Abuse-Related Events in Clinical Trials”
“Placebo Response Reduction Training in Chronic Low Back Pain: Comparison to Other Published Studies on Chronic Low Back Pain”
- IASP World Congress on Pain (Boston, MA):
- Pain and Migraine Therapeutics Summit (San Francisco, CA):